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Abstract
Background: The amyloid-b (Ab) peptide is the primary component of the extracellular senile plaques characteristic of
Alzheimer’s disease (AD). The metals hypothesis implicates redox-active copper ions in the pathogenesis of AD and the Cu
2+
coordination of various Ab peptides has been widely studied. A number of disease-associated modifications involving the
first 3 residues are known, including isomerisation, mutation, truncation and cyclisation, but are yet to be characterised in
detail. In particular, Ab in plaques contain a significant amount of truncated pyroglutamate species, which appear to
correlate with disease progression.
Methodology/Principal Findings: We previously characterised three Cu
2+/Ab1–16 coordination modes in the physiological
pH range that involve the first two residues. Based upon our finding that the carbonyl of Ala2 is a Cu
2+ ligand, here we
speculate on a hypothetical Cu
2+-mediated intramolecular cleavage mechanism as a source of truncations beginning at
residue 3. Using EPR spectroscopy and site-specific isotopic labelling, we have also examined four Ab peptides with
biologically relevant N-terminal modifications, Ab1[isoAsp]–16, Ab1–16(A2V), Ab3–16 and Ab3[pE]–16. The recessive A2V
mutation preserved the first coordination sphere of Cu
2+/Ab, but altered the outer coordination sphere. Isomerisation of
Asp1 produced a single dominant species involving a stable 5-membered Cu
2+ chelate at the amino terminus. The Ab3–16
and Ab3[pE]–16 peptides both exhibited an equilibrium between two Cu
2+ coordination modes between pH 6–9 with
nominally the same first coordination sphere, but with a dramatically different pH dependence arising from differences in H-
bonding interactions at the N-terminus.
Conclusions/Significance: N-terminal modifications significantly influence the Cu
2+ coordination of Ab, which may be
critical for alterations in aggregation propensity, redox-activity, resistance to degradation and the generation of the Ab3–6
(6=40/42) precursor of disease-associated Ab3[pE]–x species.
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Introduction
Alzheimer’s disease (AD) is a neurodegenerative disorder
characterised by progressive cognitive and memory impairment
[1]. Amyloid plaques, comprising of extracellular cerebral deposits
of insoluble Ab, are the pathological hallmark of AD [1,2]. Within
these plaques, copper is found in high concentrations [2,3] and
growing evidence suggests that copper ions play an important role
in the pathogenesis of AD by inducing protein misfolding and
generating reactive oxygen species [4,5,6,7,8,9]. It is generally
accepted that soluble, low molecular-weight oligomers are
responsible for the neurotoxic effects of Ab [10] and although
full consensus is still lacking, copper clearly influences the
oligomerisation pathway of Ab [9,11–14].
The Cu
2+ coordination of Ab1–x peptides (6=16, 28, 40, 42) is
now well characterised, with the Ab1–16 fragment containing all
residues essential for its highest affinity coordination. Using
electron paramagnetic resonance (EPR) spectroscopy and site
specific
17O,
15N and
13C labelling, we recently introduced a
refined model of Cu
2+/Ab interactions. Between pH 6–7, two
dominant coordination modes are in equilibrium (components Ia
and Ib), with a 5-membered chelate being formed between Cu
2+,
the amino nitrogen and (in at least one of the components) the
backbone carbonyl of Asp1, together with nitrogen coordination
by His6 and His13 (Ia) or His14 (Ib) [15,16]. Using a similar
approach, these findings have recently been reproduced [17]. At
pH.7, an additional coordination mode (component II) is also
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e15875populated and in equilibrium with component I species. Although
the precise ligand sphere of component II remains contentious
[15–17], we have used
15N- and
13C-labelling to identify the
coordination of the carbonyl of Ala2, while site specific
15N-
labelling and multifrequency CW-EPR simulations supported
simultaneous coordination of His6, His13 and His14 in a {CO
A2,
NIm
H6,N Im
H13,N Im
H14} coordination sphere [15].
In contrast to Ab1–x, little has been reported about the Cu
2+
coordination of Ab with N-terminal truncations or modifications, yet
the deposition of extracellular Ab in vivo is accompanied by a large
degree of amino-terminal heterogeneity. Early studies of the plaque
core of AD patients identified a significant proportion of Ab peptides
with ragged N-termini [18,19]. Of these, truncated pyroglutamate
forms, particularly Ab3[pE]–6 (6=40/42), are now believed to
constitute a major component of amyloid found in senile plaques of
AD patients [20–25] and of the amyloid detected by positron
emission tomographic (PET) imaging [26]. Ab3[pE]–40 also
correlates with the extent of Ab deposition in cerebral blood vessels
[24]. The accumulation of Ab3[pE]–x in AD is consistent with a
resistance to degradation by aminopeptidases, a property displayed
by a range of proteins and peptides with an amino terminal pGlu
residue [27]. In both neuronal and glial cell cultures [28,29],
Ab3[pE]–40 induces significantly more cell loss than Ab1–40 and
Ab1–42 while intracerebroventricular injection of soluble Ab3[pE]–
42 or Abl–42 in wild type (wt) mice leads to reduced cognitive
performance and induces neuronal apoptosis in vitro [ 2 8 ] .I na nA P P /
PS1KI mouse model of AD, a continuous rise in Ab3[pE]–x plaque
load and a concomitant decrease in Ab1–x was observed with
increasing age, suggesting that Ab1–x peptides are N-truncated as
disease progresses [30]. In vitro,A b3–x and Ab3[E]–6 (6=40,42)
aggregate to form fibrillar structures more rapidly than Ab1–x and
accelerate Ab1–x fibril formation [31,32], with Ab3[pE]–40
displaying faster aggregation compared with Ab3–40 [32]. Notably,
Ab3–42 seeding of Ab1–40 fibril formation at pH 7.4 is greatly
enhanced in the presence of substoichiometric Cu
2+ [31]. We have
demonstrated that the first two residues of Ab1–x are both directly
involved in Cu
2+ coordination of Ab1–16 [15,16]; however, the
coordination of the more toxic Ab3[pE]–x species and its Ab3–x
precursor have not been investigated in detail. Furthermore, the
mechanism of N-terminal truncation remains unknown.
In addition to Ab42 and Ab3[pE]–42, the amyloid cores from
AD brain tissue contain other post-translational modifications
including isomerised and racemised Ab, in particular Ab1
[isoAsp]–42 and Ab1[D-Asp]–42 [22,33]. Isoaspartate (isoAsp)
formation is also associated with impaired protein function and
enhanced isomerisation affects both Ab and the tau protein in AD
[34]. It can be generated spontaneously from Asp and Asn residues
via formation and subsequent hydrolysis of a cyclic L-succinimidyl
intermediate [35] and has been shown to form upon ageing of
Ab1–16 in vitro [36]. Although the physiological consequences of
isomerisation remain unclear, it results in an increased tendency of
Ab to form b-sheet in vitro [37] and was proposed to enhance the
stability of Ab deposits in AD brain tissue [33]. More recently, the
Zn
2+ coordination of Ab1–16[isoAsp7] was studied by NMR and
shown to directly coordinate via isoAsp7 (whereas Asp7 of the
native Ab1–16 does not) [36], and was subsequently shown to
induce oligomerisation of Ab1–16[isoAsp7] [38]. The latter
property was proposed to be potentially relevant to the D7N
Tottori–Japan mutation, in light of the greater susceptibility of
asparagine to spontaneous conversion into isoAsp [38]. In contrast
to isomerisation of Asp7, there are no reported studies describing
the properties of Ab1[isoAsp]–x. Given the importance of Asp1 to
the Cu
2+ coordination of the native peptide, it is of interest to
characterise this species.
Tagliavini and co-workers recently identified a new recessive
A673V mutation in the amyloid precursor protein that generates
an Ab(A2V) peptide [39], which appears to be associated with
disease only in the homozygous carriers. In vitro studies of synthetic
peptides demonstrated enhanced fibril formation of Ab(A2V) in
isolation, but co-incubation of wt Ab1–40 with Ab1–40(A2V) or
even Ab1–6(A2V) inhibited amyloid formation of the native
peptide. Moreover, the viability of cultured human neuroblastoma
cells was significantly reduced by Ab1–42(A2V) compared with wt
Ab1–42. This anti-amyloidogenic effect in vitro was suggested to be
responsible for the autosomal negative pattern of inheritance [39].
Since trace copper does not appear to have been accounted for in
the above study, and the carbonyl of Ala2 in wt Ab1–x coordinates
Cu
2+ [16], it is natural to ask how this coordination might be
modified in this rare familial form of AD.
It is clear that the N-terminal modifications of Ab, especially
pGlu forms beginning at residue 3, are strongly associated with
disease. Since Cu
2+ coordination modulates peptide aggregation
and toxicity of Ab1–x [40], and this coordination involves the first
two residues, we have synthesised four N-terminally modified Ab
peptides Ab1[isoAsp]–16, Ab1–16(A2V), Ab3–16 and Ab3[pE]–
16, and characterised their pH-dependent Cu
2+ coordination
using EPR spectroscopy. The potential physiological consequences
of the changes observed with respect to the Cu
2+ coordination of
the wt peptide are discussed and a Cu
2+-dependent mechanism of
N-terminal truncation is also hypothesised.
Materials and Methods
Peptide synthesis
Table 1 lists the peptides synthesised for this study. Fmoc-
L-
15N-Val-OH (
15N, 98%) and Fmoc-L-
13C(1)-Val-OH (
13C(1),
99%) were purchased from Cambridge Isotope Laboratories.
Fmoc-L-
13C(1)-Asp-OH (
13C(1), 99%), was purchased from Sigma
Aldrich. Solid phase peptide synthesis was carried out in the
Peptide Technology Facility of the Bio21 Molecular Science and
Biotechnology Institute, The University of Melbourne, using
standard protocols with HOBt/DIC as coupling reagents.
Unlabelled Ab1–16 (DAEFRHDSGYEVHHQK-OH), Ab3–16
(EFRHDSGYEVHHQK-OH) and Ab3[pE]–16 ([pE]FRHDS-
GYEVHHQK-OH) (using L-Pyroglutamic acid for the final
coupling) were synthesised by solid-phase peptide synthesis on
Fmoc-L-Lys(Boc)-PEG-PS resin (Applied Biosystems) using a
CEM Liberty microwave peptide synthesiser. Ab1–16(
13C(1)-
Asp1), Ab1–16(
13C(1)-isoAsp1), Ab1–16(A2V,
15N-Val2), and
Ab1–16(A2V,
13C(1)-Val2) were similarly synthesised using the
CEM Liberty microwave peptide synthesiser, except that the
appropriate labelled Fmoc amino acid was manually coupled.
Table 1. Abx–16 peptide sequences employed in this study,
with labelled residues given in boldface.
Ab1–16 DAEFRHDSGYEVHHQK-OH
Ab3–16 EFRHDSGYEVHHQK-OH
Ab3[pE]–16 [pE]FRHDSGYEVHHQK-OH
Ab1[isoAsp]–16(
13C(1)-isoAsp1)
a DAEFRHDSGYEVHHQK-OH
Ab1–16(A2V,
15N-Val2)
b DVEFRHDSGYEVHHQK-OH
Ab1–16(A2V,
13C(1)-Val2)
c DVEFRHDSGYEVHHQK-OH
a13C(1)-Asp/isoAsp = NH2CH(CH2COOH)
13COOH.
b15N-Val =
15NH2CH(CHCH3CH3)COOH.
c13C(1)-Val = NH2CH(CHCH3CH3)
13COOH.
doi:10.1371/journal.pone.0015875.t001
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16(
13C(1)-isoAsp1), the N-terminal Fmoc-L-
13C(1)-Asp-OH was
coupled without any protection of the C(4)OO
2 group. This
produced both a (Asp1) and b (isoAsp1) isomers, which were then
separated by RP-HPLC and their identity confirmed by Edman
degradation. Using the final RP-HPLC trace, final peptide purity
was determined to be . 96% for Ab1–16(
13C(1)-isoAsp1), . 98%
for Ab3–16, . 99% for Ab3[pE]–16, . 92% for Ab1–
16(A2V,
15N-Val2), and . 94% for Ab1–16(A2V,
13C(1)-Val2).
Sample preparation
The lyophilised Ab peptides were suspended in phosphate
buffered saline (10 mM phosphate buffer, 2.7 mM KCl, 137 mM
NaCl; Sigma product number P4417) at concentration of
,1.25 mM, as determined using an extinction coefficient at
280 nm of 1280 M
–1cm
–1. A concentrated stock of
65CuCl2 was
prepared by stirring
65CuO (
65Cu, .99%; Cambridge Isotope
Laboratories) in concentrated HCl and diluted in milliQ water. To
the peptide solutions, 0.9 molar equivalents
65CuCl2 was added,
the pH was measured using a micro-probe (Hanna Instruments,
Italy) and adjusted using concentrated NaOH or HCl. Glycerol
was added at 10% v/v to ensure good glass formation upon
subsequent freezing. Final peptide concentrations were ,1.0 mM.
Samples were transferred to quartz EPR tubes (Wilmad, SQ-707)
and snap-frozen in liquid nitrogen within minutes of metal
addition.
CW-EPR spectroscopy
X-band CW-EPR was performed using a Bruker ESP380E
spectrometer fitted with a rectangular TE102 microwave cavity and
a quartz cold finger insert. Microwave frequencies were measured
with an EIP Microwave 548A frequency counter and g factors
calibrated against the F
+ line in CaO (g=2.0001 6 0.0002).
Experimental conditions were: microwave power, 10 mW;
microwave frequency, 9.42 GHz; modulation amplitude, 4 G;
modulation frequency, 100 kHz; temperature, 77 K; sweep time,
168 s; time constant, 164 ms; 8 averages. Background correction
was performed by subtraction of the sample-free spectrum. Second
derivative spectra were obtained by differentiating the first
harmonic spectrum, followed by Fourier filtering using a
Hamming window to remove high frequency noise, ensuring the
spectrum was not distorted. The spin Hamiltonian (SH)
parameters of each coordination mode were determined from
numerical simulations of the CW-EPR spectra using version 1.1.4
of the XSophe-Sophe-XeprView computer simulation software
[41] on an i686 PC running Mandriva 2007, as described in detail
in our earlier study [15].
HYSCORE spectroscopy
To measure superhyperfine (shf) interactions between Cu
2+ and
remote, non-coordinating nuclei, electron spin echo envelope
modulation (ESEEM) experiments were performed at X-band
using a Bruker ESP380E spectrometer fitted with a Bruker ER
4118 dielectric resonator, an Oxford Instruments CF935 cryostat
and a 1kW TWT amplifier. Two-dimensional hyperfine sublevel
correlation (HYSCORE) experiments were carried out at 15 K
using a p/2–t–p/2–t1–p–t2–p/2–t–echo sequence and pulse
lengths of tp/2=16 ns and tp=24 ns, with a 4–step phase cycle
to eliminate unwanted echoes. The time intervals t1 and t2 were
varied from 48 ns to 8176 ns in steps of 64 ns (Nyquist frequency
of 7.81 MHz); a value of t=144 ns was used to minimise blind
spots below 7 MHz and to suppress ubiquitous
1H modulation
and its subsequent frequency foldback [42]. In all spectra, the real
part of the time-domain quadrature signal was selected, back-
ground corrected in both dimensions using a low-order polynomial
fit, zero-filled to 2566256 data points and apodised with a
Hamming window function. Following 2D-FFT, the absolute
value was computed and to minimise artefacts the two-dimen-
sional spectra were symmetrised by setting S9(nj,ni)=S9(ni,nj)=
min[S(ni,nj), S(nj,ni)], where S and S9 refer to the frequency-domain
signal before and after symmetrisation.
Results
Isomerisation of Asp1 inhibits component II coordination
by forming a stable 5-membered chelate
X-band CW-EPR of Cu
2+/Ab1[isoAsp]–16 indicated the pres-
ence of only a single coordination mode with only subtle variation in
linewidth between pH 6–8 (Figure 1), possibly due to pH-dependent
structural changes beyond the first coordination sphere. This
contrasts with the Ab1–16 peptide at pH 8.0 (Figure 1), where
component II is also populated, and indicates that isomerisation of
Asp1 permits a highly stable coordination geometry inaccessible to
the wt peptide. The SH parameters of the coordination mode are
distinct from, but similar to, those of component I coordination mode
of Cu
2+/Ab1–16 (Table 2). The above observations can be explained
if Cu
2+/Ab1[isoAsp]–16 forms a stable 5-membered ring via the
amino terminus and the carboxylate of isoAsp1 (Figure 2a), similar to
the 5-membered chelate adopted by oxidised glutathione, in which
the first residue of the tripeptide is isomerised glutamate [43]. We
previously proposed a similar 5-membered chelate in the native
peptide [16], however in this instance the oxygen coordination was
via the carbonyl of Asp1 (Figure 2b).
Simulation of the CW-EPR spectrum yielded principal g and
A||(Cu) parameters consistent with a 3N1O coordination sphere
[44,45], and resonances due to metal-ligand shf coupling were also
well fitted assuming 3 nitrogen ligands (Figure 3). Further evidence
for the coordination shown in Figure 2a was obtained from pulsed
EPR spectroscopy. Although difficult to detect near gH, the
HYSCORE spectrum of Cu
2+/Ab1[
13C(1)-isoAsp]–16 obtained
at a magnetic field near g|| exhibited correlation ridges centred on
the
13C Larmor frequency with a splitting of ,4 MHz, consistent
with equatorial carboxylate coordination of isoAsp1 (compare
Figure 4c,d with Figure 5c-d). Cross peaks were also observed at
(ndq, n+) , (4, 1.6) MHz and (ndq, n–,0) , (4, 0.8) MHz due to
electron-nuclear coupling with the distal
14Nt nucleus of
equatorially coordinated His, where the n0,2 and n+ frequencies
derive from transitions within the a electron spin manifold and ndq
derives from the b manifold [46]. Additionally, combination peaks
at (ndq, n+ + n2) < (4, 2.5) MHz and (ndq,2 n+) < (4, 3.2) MHz
were present (Figure 4c,d), similar to those observed for other Cu
2+
binding proteins where the metal is coordinated by two His
residues [47]. These combination peaks were not readily apparent
in the HYSCORE spectra of unlabelled Ab1–16 at physiological
pH (Figure 4a-b, Figure 5a-b), even though we have previously
established from multifrequency CW-EPR that this peptide
simultaneously coordinates via at least two histidine ligands
[15,16]; however, it is frequently the case that combination lines
are weak and their appearance is highly system-dependent [48].
The resonance lines from individual electron-nuclear couplings are
additive in pulsed EPR methods such as HYSCORE, as opposed
to the multiplicative nature of the shf interactions in CW-EPR;
hence in principle the ESEEM lines of from His coordination need
not originate from the same coordination mode as the lines due to
carboxylate coordination. However, CW-EPR indicates only a
single species is present over a wide pH range, therefore we may
safely assign all of the features to the coordination proposed in
Figure 2a.
Cu
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sphere of Cu
2+/Ab
CW-EPR indicated the presence of an equilibrium between
multiple species in Cu
2+/Ab1–16(A2V) very similar to wt peptide
with respect to the principal g|| and A||(Cu) parameters (Table 2),
as well as the position of their shf resonances (Figure S1). However,
in comparison with Cu
2+/Ab1–16, the onset of the high-pH signal
begins approximately 0.5 pH units higher as the pH is (Figure 1).
The g||/A|| ratio of 142 cm for the high pH mode falls outside the
normal range (105–135 cm) for normal square planar Cu
2+
complexes, indicating that its first coordination sphere, similar to
component II of Ab1–16, is tetrahedrally distorted [44].
The similar Cu
2+ coordination of the wt and A2V peptides was
further confirmed by the appearance of
15Nam(Val2) cross peaks,
concomitant with the disappearance of
14Nam(Val2) cross peaks, in
the HYSCORE spectrum of Cu
2+/Ab(A2V,
15N-Val2) at pH 6.3
(Figure 4g; Figure 5g). These features were also previously
observed for Cu
2+/Ab1–16(
15N
13C-Ala2) and provide evidence
for carbonyl coordination of Asp1 at low pH [16]. At pH 8.5,
HYSCORE spectroscopy of Cu
2+/Ab1–16(A2V,
13C(1)-Val2)
identified cross peaks consistent with equatorial coordination of
13C=O coordination of residue 2 (Figure 4h; Figure 5h). Once
again,
13C=O features were similarly observed for Cu
2+/Ab1–
16(
15N
13C-Ala2) at pH 8.0 [16]. However, the topology of the
13C=O cross-peaks at both 3085 G (near g||) and 3370 G (near
gH) is clearly different in comparison with the wt complex [16],
indicating a perturbation of the outer coordination sphere of the
A2V variant in coordination geometry of residue 2 upon replacing
Ala with Val. Although there appear to be two pairs of
13C cross-
peaks in Figure 4h, this clearly cannot be due to bidentate
coordination of Val2 (via the amide N and carbonyl O), since only
the C(1) (carbonyl) nucleus was
13C-labelled. There is also no
evidence for an additional independent coordination mode
involving C=O (Val2) that could generate a second set of cross-
peaks. It is possible that the effect is the result of ‘‘holes’’ arising
from destructive interference of the double quantum
14Nt
correlation frequency and
13C correlation frequency, with each
possessing a different phase [49].
Overall, the combined CW-EPR and HYSCORE data indicate
the identity of first coordination sphere of Cu
2+/Ab1–16(A2V) is
the same as the wt peptide in both low pH and high pH modes;
however, the replacement of the -CH3 side chain (Ala2) with a
larger -CH(CH3)2 group (Val2) produces changes in the outer
coordination sphere that lead to a modest shift in the onset of the
component II-like coordination mode by approximately +0.5 pH
units compared with Cu
2+/Ab1–16. Previous CW-EPR studies of
Cu
2+/Ab2–16 and Cu
2+/Ab1–16(D1N) inferred that the ratio of
components I and II of the native Cu
2+/Ab system is related to a
hydrogen bonding interaction of COO
2 (Asp1) with a protonated
moiety in the outer coordination sphere, rather than a change of
the coordinating ligands, because the SH parameters of each
component appeared unchanged [50,51]. This indirect role for
COO
2 (Asp1) as a non-coordinating ligand has since been
confirmed by HYSCORE studies of Cu
2+/Ab1–16(
13C(4)-Asp1),
Figure 1. X-band (9.43 GHz) CW-EPR spectra of Cu
2+/Ab1–16,
Cu
2+/Ab1–16(A2V), Cu
2+/Ab1[isoAsp]–16, Cu
2+/Ab3–16 and
Cu
2+/Ab3[pE]–16 (0.9 equiv
65CuCl2). For comparative purposes,
dashed vertical lines identify the position of the resolved A||(
65Cu)
resonances corresponding to component Ia/b and component II of
Cu
2+/Ab1–16. Spectra of Cu
2+/Ab1[isoAsp]–16 and Cu
2+/Ab1–16(A2V)
correspond to the
13C(1)-isoAsp1 and
13C(1)-Val2 labelled analogues,
respectively.
doi:10.1371/journal.pone.0015875.g001
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Peptide g|| gH A||(
63Cu)
a AH(
63Cu)
a aiso (ligand nuclei) Ref
Ab1[isoAsp]–16
{NH2
D1, COO
2 D1,N Im,N Im} 2.25560.002 2.05460.002 18562 14.360.5 10.660.5 This work
c
13.160.5
14.760.5
Ab1–16, Ab1–16(A2V)
{NH2
D1,C O
A2,V2,N Im
H6,N Im
H13/H14} 2.27260.005 2.05660.005 17163 14.560.5 11.360.5 (
14Na
D1) [15,16],
(‘‘component Ia/b’’) 13.060.5 (
14NIm
H6) this work
b,c
14.060.5 (
14NIm
H13/H14)
{CO
A2,N Im
H6,N Im
H13,N Im
H14} 2.22760.003 2.04360.003 15763 21.061.0 15.061.0 (
14NIm
H6) [15,16],
(‘‘component II’’)
d 12.561.0 (
14NIm
H13) this work
b,c
12.561.0 (
14NIm
H14)
Ab3–16, Ab3[pE]–16
{3N1O} ‘‘low pH’’
e 2.26160.002 2.05360.002 18361 16.860.5 12.160.5 (
14N1) This work
b
14.360.5 (
14N2)
15.960.5 (
14N3)
{4N} ‘‘high pH’’
f 2.19460.002 2.03460.002 19361 16.360.5 10.660.5 (
14N1) This work
b
13.260.5 (
14N2)
14.260.5 (
14N3)
16.160.5 (
14N4)
Ab4–16
{4N} 2.17860.001 2.049 20961 n.d.
g n.d. [50]
aAll hyperfine parameters are expressed in units of Ai [10
24cm
21]=Ai [MHz]/2.9979 = Ai [G] 610
4(gibe/hc), where i =| |o rH, h is Plank’s constant, c = 2.9979
610
10cm.s
21 and be = 9.274610
228 J.G
21.
gTo aid comparison with other work in which natural abundance copper (69%
63Cu, 31%
65Cu) has been used, hyperfine couplings have been converted from
65Cu to
those expected for
63Cu using the scaling factor |gn(
65Cu)/gn(
63Cu)| = 1.07. Uncertainties in parameters represent the estimated range.
cSH parameters from simulation of wt peptide [15].
d{NH2
D1,N am
A2,C O
A2,N Im
H6} coordination has also been proposed [17].
eParameters based upon simulation of Cu
2+/Ab3[pE]–16 at pH 6.9.
fParameters based upon simulation of Cu
2+/Ab3–16 at pH 8.5.
gn.d. = not determined.
doi:10.1371/journal.pone.0015875.t002
Figure 2. Two-dimensional representation of the 5-membered chelate formed by (a) Cu
2+/Ab1[isoAsp]–16 and (b) Cu
2+/Ab1–16 (R =
CH3) and Cu
2+/Ab1–16(A2V) (R = CH2(CH3)3), with one possible H-bonding interaction shown. The coordination in (b) only predominates
below pH 8, whereas the stable chelate in (a) remains the sole coordination mode (Figure 1).
doi:10.1371/journal.pone.0015875.g002
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13C-labelling of the side chain carboxylate failed
to reveal
13C cross-peaks diagnostic of equatorial coordination
[16]. The shift in the pH-dependent equilibrium upon replacing
Ala2 with Val, without a change in SH parameters, suggests the
side chain of the second residue plays a similar indirect role,
however the A2V mutation shifts the equilibrium in the opposite
direction (subtle decrease in high pH mode) compared with the
D1N mutation (significant increase in high pH mode).
Coordination of truncated Cu
2+/Ab3–16 and Cu
2+/
Ab3[pE]–16
CW-EPR of Cu
2+/Ab3–16 and Cu
2+/Ab3[pE]–16 revealed a
pH-dependent equilibrium between two main components in the
physiological pH range (Figure 1). Interestingly, both Cu
2+/Ab3–
16 and Cu
2+/Ab3[pE]–16 possessed very similar coordination
modes, but the pH-dependence was different in each, with the
onset high-pH signal beginning approximately 1 pH unit lower for
Cu
2+/Ab3–16 (Figure S2) as the pH was raised. The positions of
the A||(Cu) hyperfine resonances, as well as the metal-ligand shf
resonances, were highly similar for Cu
2+/Ab3–16 and Cu
2+/
Ab3[pE]–16 at both low and high pH, suggesting that neither the
free amino terminus nor the COO
2 (Glu3) side chain of Ab3–16
directly coordinates Cu
2+. The principal g and A||(Cu) parameters
obtained from numerical simulations (Figure 6, Figure 7) were
consistent with a 3N1O coordination mode at low pH and a 4N
mode at high pH [44,45] and these assignments were further
supported by the simulation of the shf resonances (Table 2).
HYSCORE spectroscopy of Cu
2+/Ab3–16 and Cu
2+/Ab3[pE]–
16 each showed similar features due to histidine
14Nt nuclei at pH
,7 and pH 9.0 (Figure S3), indicating that at least one His side
chain coordinates in both the 3N1O and 4N modes, with the
remaining nitrogen ligands coming from deprotonated backbone
amide groups. The absence of
14N features characteristic of a non-
coordinating nearby amide N (Figure S3) indicated a carbonyl can
be excluded as an oxygen ligand in the low pH 3N1O
coordination mode.
Raman spectroscopy and aggregation studies of Cu
2+ coordi-
nation of related Ab3–9(E3A), Ab3–9(H6A), Ab3–9(D7A) or Ac-
Ab3–9 peptides suggested that the amino terminus, His6 and the
carboxylate groups of Glu3 and Asp7 coordinate Cu
2+ in Ab3–9 at
pH 6 [52]. The coordination of the amino group was suggested
based upon the ability of Cu
2+/Ab3–9 to form amyloid between
pH 4–8, but not Cu
2+/Ac-Ab3–9 [52]. However, it is unclear
whether simultaneous coordination of each of the above
mentioned residues was implied; certainly, the simultaneous
coordination of the amino terminus and the carboxylate side
chain of Glu3 would require a highly unfavourable 7-membered
chelate ring. Direct comparisons between Cu
2+/Ab3–9 and Cu
2+/
Ab3–16 are difficult to make, since no EPR data is available for
Ab3–9 and the consequences for Cu
2+ coordination of truncation
at Gly9 on are unknown.
A different pH-dependence of the occupancy of the 3N1O and
4N coordination modes for Cu
2+/Ab3–16 and Cu
2+/Ab3[pE]–
16, without a major perturbation of their SH parameters, suggests
the N-terminal Glu plays an indirect role in a manner similar to
that of Asp1 in controlling the ratio of components I and II signals
of Cu
2+/Ab1–16 and Cu
2+/Ab1–16(D1N). A key difference,
however, is that the loss of the carboxylate side chain upon
cyclisation of Glu3 leads to a reduction of the occupancy of the
high-pH species, which compares with the increase in the high pH
species observed for Cu
2+/Ab1–16(D1N) and Cu
2+/Ab2–16 in
comparison with Cu
2+/Ab1–16 [50].
Discussion
In this study, we have investigated the Cu
2+coordination of four
model Ab peptides with physiologically relevant N-terminal
modifications or truncations. With the exception of Cu
2+/
Ab1[isoAsp]–16, which possesses a single dominant coordination
mode, all peptides exhibited equilibria between multiple pH-
dependent Cu
2+ coordination modes in the physiological pH
range.
The CW-EPR spectra of Cu
2+/Ab1[isoAsp]–16 showed that
the shorter carboxylate-bearing side chain of isoAsp1 enables a
stable five-membered ring to form between Cu
2+, the amino
terminus and the carboxylate oxygen. HYSCORE spectroscopy
provided direct confirmation of equatorial coordination by the
carboxylate oxygen of isoAsp1, in addition to two His side chains.
The {NH2
D1, COO
2 D1,2 N Im} coordination is similar to the 5-
membered ring we previously proposed for wt Ab at low pH,
involving the amino nitrogen and the backbone carbonyl of Asp1
(components Ia and Ib) [16]; however, its stability is greatly
increased compared with component I such that the high pH
coordination mode observed at pH .7i nw tA b1–16 (component
II), or any potential alternative arising from the modified peptide
backbone, is eliminated at all physiologically relevant pH values.
The Ab(A2V) peptide derives from a recently identified familial
APP mutation [39]. A number of observations in this study
indicated that the A2V mutation alters the outer coordination
Figure 3. Simulation of the X-band CW-EPR spectrum of Cu
2+/
Ab1[isoAsp]–16 at pH 6.9. (a) First derivative. (b) Second derivative,
expanded around gH region. Simulation parameters appear in Table 2.
Experimental spectra correspond to the
13C(1)-isoAsp1 labelled
analogue.
doi:10.1371/journal.pone.0015875.g003
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2+/Ab1–16, but not the identity of the
coordinating ligands. Comparison of CW-EPR spectra of Cu
2+/
Ab1–16(A2V) identified the presence of low pH and high pH
signals with principal g and A values and ligand shf splitting almost
indistinguishable from components Ia/b and component II of
Cu
2+/Ab1–16. HYSCORE spectroscopy confirmed that C=O
(Val2) coordinates in the high pH mode in a manner similar to
Ala2 in Cu
2+/Ab1–16 [16], and that C=O (Asp1) coordination
occurs at low pH analogous to Cu
2+/Ab1–16 [16]. Noteworthy
was the subtle shift in the pH dependence of the coordination
modes by ,0.5 pH units in response to the A2V mutation.
Coupled with the known pH dependence of the coordination
modes on the outer sphere interactions of COO
2 (Asp1) [51], this
suggests the mutation may either provide steric influences that
could either enhance the strength of any H-bonding or salt bridge
[53] interactions involving Asp1, or destabilise the high pH
coordination mode via its side chain interactions independently of
Asp1.
In the case of Cu
2+/Ab3–16 and Cu
2+/Ab3[pE]–16, CW-EPR
suggested that the N-terminus plays a key role in controlling the
ratio of the low and high pH signals without directly coordinating
Cu
2+. Since changes in the first coordination sphere do not always
lead to significant perturbation of the SH parameters, it remains
possible that the coordinating ligands in one or both modes are in
fact different for Cu
2+/Ab3–16 and Cu
2+/Ab3[pE]–16, in
particular that Glu3 coordinates Cu
2+/Ab3–16. However, the
shift in the pH dependence may also be rationalised by differences
in outer coordination sphere interactions alone. Since N-terminal
pGlu is known to affect a protein’s structural stability [54], our
observations suggest that pGlu could alter the relative stability of
the high pH mode in Cu
2+/Ab3[pE]–16, either by participating
hydrogen bonding interactions in the outer coordination sphere
(eg. as an H-bond acceptor via the Oe of pGlu and/or an H-bond
donor via its amide N) [54], by eliminating H-bonding or salt
bridge interactions [53] that are present in Cu
2+/Ab3–16, or by
increasing the pKa of a Cu
2+ ligand that directly participates in the
high pH mode (eg. between the Oe of pGlu and a coordinating
backbone amide N). These possibilities, together with more
definitive ligand assignments, including the identity of the
coordinating oxygen, imidazole and amide nitrogen ligands, await
quantitative assessment by isotopic labelling of residue 3 and other
key residues. However, it is clear from the present data that
cyclisation of Glu3 has a significant impact on the Cu
2+
coordination properties Ab with N-terminal pyroglutamate.
Could Cu
2+ promote N-terminal truncation of Ab?
While cyclisation of the N-terminal glutamate of Ab3–x appears
to be enhanced by glutaminyl cyclase [55,56], the process leading
to the production of the Ab3–x precursor itself remains unclear.
Recently, the extracellular glutamyl aminopeptidase (aminopepti-
dase A) has been shown to cleave Asp1 from Ab in both cell free
and cell culture models [57], however this alone appears
insufficient to explain the generation of truncations at position 3.
In principle, a second successive degradation step on Ab2–x by
alanyl aminopeptidase (aminopeptidase N), which accounts for
approximately 80% of the total soluble aminopeptidase activity in
the human cortex [58,59], could account for Ab3–x formation in
conjunction with glutamyl aminopeptidase activity. However,
alanyl aminopeptidase has limited activity against Ala-X sequences
with acidic X residues [58], aminopeptidase and didpetidyl
aminopeptidase activity is not significantly higher in soluble
extracts of frontal cortex from AD brains [59], and overall Ab
production does not increase most in familial forms of AD or with
age [40]. Hence, there is presently insufficient evidence to
conclude that any specific aminopeptidase activity is responsible
for generation of the Ab3–x precursor of Ab3[pE]–x in AD.
Kowalik-Jankowska and co-workers analysed the products of
Cu
2+ catalyzed oxidation of human and mouse (R5G, Y10F,
H13R) Ab1–16 in the presence of hydrogen peroxide [60,61]. A
range of oxidatively modified species including fragmentation
products obtained by peptide bond cleavage were observed. For
the mouse peptide, Ab3–16 fragments generated by a-amidation
and diamide pathways were identified (the latter fragment also
contained 2-oxo-His). Since Cu
2+/Ab interactions are believed to
produce hydrogen peroxide in vivo [62,63] and the Ab3–16
fragment generated by the diamide pathway leaves a free amino
nitrogen, this represents a plausible source of truncated Ab3–16.
However, while a number of fragmentation products were
generated in both mouse and human peptides, specific Ab3–16
products were reported only for the mouse Ab [60].
Upon identification of C=O (Ala2) as the oxygen ligand in
component II coordination of Ab, we recently proposed an
alternate peptide cleavage mechanism based upon Cu
2+-promoted
amide hydrolysis, following polarisation of the C=O bond of the
coordinating carbonyl of Ala2 [16]. Such a process is proposed to
underlie the activity of metallohydrolases such as carboxypeptidase
A and thermolysin, and possible mechanisms have been described
in some detail [64–66]. Based upon such mechanisms, a
hypothetical hydrolysis reaction generating Ab3–16 is presented
in Figure 8. This mechanism could involve a Cu
+ intermediate
(Figure 8), allowing for the additional possibility of oxygen
activation and ROS formation as a side reaction.
Unlike metallohydrolases, the requirement for intramolecular
cleavage of the amide bond in Ab, as opposed to enzymatic
cleavage of an extramolecular substrate, naturally precludes a
catalytic mechanism. While the Ab1–x stabilised in senile plaques
contains bound Cu
2+ [67] and could conceivably undergo
hydrolysis, soluble Ab3[pE]–x species that are thought to be
involved in disease initiation must be generated prior to formation
of extracellular amyloid and hence prior to Ab turnover. While
very large rate increases have been reported in the presence of
metals such as copper and zinc, amide hydrolysis generally
involves a tetrahedral intermediate with a poor RNH- leaving
group that must be protonated either prior to or in concert with C-
N cleavage, meaning the reaction is usually very slow at pH 7
(Figure 8) [64]. Ie. the number of cleavage events that would occur
prior to turnover of soluble Ab1–x would be exceedingly small.
Nevertheless, the very gradual increase in levels of N-terminally
truncated Ab as disease progresses implies that amide hydrolysis
occurs infrequently and as such only an exceedingly small rate
constant would be required.
The rate of amide hydrolysis, in which the limiting step is
believed to be breakdown of the tetrahedral intermediate [64],
may depend critically upon stereoelectronic constraints of the
metal and the carbonyl ligand [64,68], a nearby amino acid side
chain for proton transfer to the leaving amide nitrogen [66], as
well as the identity of the attacking nucleophile. Hence, post-
translational modifications, familial mutations, binding partner or
Figure 4. X-band (9.70 GHz) HYSCORE spectra (t=144 ns) of Cu
2+/Ab16 analogues (0.9 equiv
65CuCl2), obtained at 3085 G. For
clarity, the cross-peaks between Nt single-quantum and double-quantum transitions are not marked by dashed boxes. Grey dashed boxes highlight
loss of cross-peaks.
doi:10.1371/journal.pone.0015875.g004
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65CuCl2), obtained at 3370 G (near gH).
doi:10.1371/journal.pone.0015875.g005
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oligomeric species may modulate such a process. The appearance
of Ab1(isoAsp)–x species in AD plaques is consistent with a
hydrolysis mechanism involving C=O(Ala2), since coordination
of C=O(Ala2) is absent in Cu
2+/Ab1[isoAsp]–16. In the case of
the familial A2V mutant, the subtle alteration in the pH
dependence and the change in the carbonyl coordination
geometry might be expected to affect the rate of hydrolysis.
CHO and COS-7 cells transfected with the A673V mutation have
increased secretion of Ab11–40, Ab11–42 and Ab3[pE]–42
compared with controls transfected with wt APP; however, within
the limits of uncertainty, levels of Ab1–40 and Ab1–42 were also
increased by the same ratio [39]. In vivo data on Ab3[pE]–x levels
for this inherited form of AD are presently unknown. Verification
of the mechanism in vitro may be complicated by the requirement
for additional cofactors present in vivo and a potentially very low
rate constant. Further investigation of the C. elegans model, which
predominantly expresses Ab3–42 [31], may help to elucidate the in
vivo mechanism of N-terminal truncation.
In conclusion, we have examined the changes in Cu
2+
coordination associated with N-terminal modifications that accom-
pany the accumulation of extracellular Ab in vivo, including
isomerisation, truncation and cyclisation. Using CW and pulsed
EPR spectroscopy, we have examined the changes in Cu
2+
coordination that accompany these physiologically relevant N-
terminal modifications to the Ab1–16 peptide. Isomerisation of
Asp1 enables Cu
2+/Ab1[isoAsp]–16 to form a 5-membered ring via
the amino terminus and the carboxylate of isoAsp1, with the
remaining ligands being supplied by His side chains. This
coordination is similar to component I of native Ab, except the
latter forms a less stable 5-membered chelate involving the amino
terminus and the carbonyl of Asp1. The stability of the Cu
2+/
Ab1[isoAsp]–16 coordination ensures that it is the only species
observed in CW-EPR spectra in the physiological pH range. The
recently identified familial A2V mutation appears to preserve the
firstCu
2+coordination sphereadopted byCu
2+/Ab1–16.However,
changes in outer coordination sphere interactions lead to a modest
decrease in the relative occupancy of the low and high pH modes.
Examination of the Cu
2+ coordination of truncated Ab3–16 and
cyclised Ab3[pE]–16 revealed an equilibrium between a 3N1O
species at low pH and a 4N species at high pH. The similarity of the
two modes suggests that the identity of the Cu
2+ coordinating
ligands inCu
2+/Ab3–xpeptide and Cu
2+/Ab3[pE]–x arethe same;
however, the pH dependence is dramatically different for each
peptide, with cyclisation of the negatively-charged carboxylate of
Figure 6. Simulation of the X-band CW-EPR spectrum of Cu
2+/
Ab3[pE]–16 at pH 6.9. (a) First derivative. (b) Second derivative,
expanded around gH region. Simulation parameters appear in Table 2.
doi:10.1371/journal.pone.0015875.g006
Figure 7. Simulation of the X-band CW-EPR spectrum of Cu
2+/
Ab3–16 at pH 8.5. (a) First derivative. (b) Second derivative, expanded
around gH region. Simulation parameters appear in Table 2. Additional
broadening is present in the experimental spectrum that may
correspond to the onset additional 4N coordination mode(s) at higher
pH or the presence of residual low pH coordination.
doi:10.1371/journal.pone.0015875.g007
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coordination mode. N-terminal pyroglutamate Ab peptides are
reported to be more toxic than their non-truncated counterparts
[28,29], appear to accumulate as disease progresses [30] and form
the major component of PIB-positive amyloid observed in the AD
brain by PET imaging [26]. While the origin of these truncated
species in vivo remains unclear, we speculate that Cu
2+-promoted
amide hydrolysis may provide a possible mechanism.
Supporting Information
Figure S1 Comparison of X-band CW-EPR spectra of
Cu
2+/Ab1–16 and Cu
2+/Ab1–16(A2V). Spectra of Cu
2+/Ab1–
16 were acquired in PBS adjusted to (a) pH 6.9, (b) pH 8.0 (c)
pH 9.0. (d) Weighted subtraction of spectrum a from spectrum b
to isolate component II. (e) Weighted subtraction of spectrum a
from spectrum c showing additional broadening in the gH region,
due to spectral ‘‘contamination’’ arising from partial population of
an additional high pH (4N) coordination mode. (f) Spectrum of
Ab1–16 at pH 10.6. Although this pH was used in ref [17] to
demonstrate a change in shf structure of Cu
2+/Ab1–16(
15N-Ala2)
as evidence of Nam
A2 coordination in component II, the full
spectrum, and hence the shf pattern, at this pH clearly
corresponds to a different 4N coordination mode. A comparison
of the second derivative spectra in PBS 6.9 of (g)A b1–16 (h)A b1–
16(
15N
13C-Ala2) (i)A b1–16(A2V,
13C(1)-Val2) and (j)A b1–
16(A2V,
15N-Val2), shows the position of the shf resonances of
Cu
2+/Ab1–16(A2V) are very similar to the wt complex in
component I coordination. The lower spectral resolution of the
A2V complex may reflect a greater propensity to aggregate [39].
Broadening of the shf resonances is seen in spectrum g compared
with f, arising from unresolved
15Nam
A2 interactions associated
with C=O
D1 coordination due to
15N-labelling of Ala2. For
component II-type coordination, comparison of second derivative
spectra of (k)C u
2+/Ab1–16, pH 8.0 – pH 6.9 (l)C u
2+/Ab1–
16(
15N
13C-Ala2), pH 8.0 – pH 6.9 (m)C u
2+/Ab1–16(A2V,
13C-
Val2), pH 8.5 – pH 6.9 and (n)C u
2+/Ab1–16(A2V,
15N-Val2),
pH 8.5 – pH 6.9, shows that the positions of the shf resonances of
Cu
2+/Ab1–16(A2V) are similar to the wt complex, but slightly
perturbed; this is consistent with the different
13C=O
A2
correlation ridges observed in the HYSCORE spectra of Cu
2+/
Ab1–16(
13C-Val2) at pH 8.5. Broadening of the shf resonances is
seen in spectrum l compared with k, arising from unresolved
13C
shf interactions associated with C=O
A2 coordination due to
uniform
13C-labelling of Ala2. Dashed vertical lines in spectra g – n
represent the approximate position of the shf resonances of Cu
2+/
Ab1–16 for comparative purposes. The Ab1–16(
15N
13C-Ala2)
peptide was prepared as described previously [16].
(TIF)
Figure S2 Comparison of low and high-pH Cu
2+ coor-
dination modes from X-band CW-EPR spectra of N-
terminally truncated Ab. Both coordination modes are highly
similar for each peptide; however, the onset of the high-pH signal
begins approximately 1 pH unit lower for Cu
2+/Ab3–16 as the pH
Figure 8. Postulated mechanism of Cu
2+-promoted amide hydrolysis leading to Ab truncation at Glu3. (a) Coordination of Ala2
(component II coordination mode) polarises the carbonyl carbon, allowing nucleophilic attack by OH
2, leading to (b) the formation of a tetrahedral
intermediate (TI), possibly via a Cu
+ oxidation state (alternatively, the coordination may be Cu
2+–O
2–C–); (c) subsequent breakdown of the TI
involving cleavage of the amide bond and protonation of the leaving amide. This latter step may involve the participation of a nearby amino acid side
chain for proton transfer to the leaving amide nitrogen. Additional transient interactions with other cofactors in vivo could be required to promote
formation, and importantly the breakdown, of the TI. Other biological nucleophiles may also be considered in step (a), such thiols (eg. glutathione, L-
homocysteine) or a serine hydroxyl group. The geometry of the coordinating ligands is drawn schematically only.
doi:10.1371/journal.pone.0015875.g008
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the resolved A||(
65Cu) resonances of the low and high pH modes.
(TIF)
Figure S3 X-band HYSCORE spectra (t=144 ns) of
Cu
2+/Ab3–16 and Cu
2+/Ab3[pE]–16 analogues (0.9 equiv
65CuCl2), obtained at 3150 G and 3370 G (near gH).
Spectrum in (g) was acquired with a smaller number of data points
in the time domain compared with the rest of the data set.
(TIF)
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